CervoMed (CRVO) Return on Sales (2022 - 2025)
CervoMed (CRVO) has disclosed Return on Sales for 9 consecutive years, with 927.18% as the latest value for Q4 2025.
- Quarterly Return on Sales fell 92408.0% to 927.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.73% through Dec 2025, down 506.0% year-over-year, with the annual reading at 6.73% for FY2025, 506.0% down from the prior year.
- Return on Sales hit 927.18% in Q4 2025 for CervoMed, down from 23.95% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 172.67% in Q3 2022 to a low of 927.18% in Q4 2025.
- Historically, Return on Sales has averaged 44.41% across 4 years, with a median of 1.07% in 2024.
- Biggest five-year swings in Return on Sales: changed 0bps in 2024 and later crashed -92408bps in 2025.
- Year by year, Return on Sales stood at 172.67% in 2022, then tumbled by -101bps to 0.95% in 2023, then crashed by -227bps to 3.1% in 2024, then crashed by -29780bps to 927.18% in 2025.
- Business Quant data shows Return on Sales for CRVO at 927.18% in Q4 2025, 23.95% in Q3 2025, and 3.55% in Q2 2025.